MODIFICATION
A -- Prototype Acceleration
- Notice Date
- 5/2/2017
- Notice Type
- Modification/Amendment
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of the Army, U.S. Army Medical Research Acquisition Activity, U.S. Army Medical Research Acquisition Activity, Attn: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014, Maryland, 21702-5014, United States
- ZIP Code
- 21702-5014
- Solicitation Number
- MTEC-17-02
- Archive Date
- 6/10/2017
- Point of Contact
- Lisa A. Fisher, Phone: 843-760-3356
- E-Mail Address
-
lisa.fisher@ati.org
(lisa.fisher@ati.org)
- Small Business Set-Aside
- N/A
- Description
- MTEC is excited to post this announcement for a Request for Project Proposals (RPP) for Prototype Acceleration Awards that will focus on advancing novel prototype technologies into the next major stage of development/milestone dependent upon their current maturity. Examples of the next major stage of development/milestone include, but are not limited to: late animal testing and regulatory filing, manufacturing, next clinical trial, regulatory approval, etc. The MTEC mission is to assist the U.S. Army Medical Research and Materiel Command (USAMRMC) by providing cutting-edge technologies and effective materiel life cycle management to transition medical solutions to industry that protect, treat, and optimize Warfighters' health and performance across the full spectrum of military operations. MTEC is a biomedical technology consortium collaborating with multiple government agencies under a 10-year renewable Other Transaction Agreement (OTA), Agreement No. W81XWH-15-9-0001, with the U.S. Army Medical Research Acquisition Activity (USAMRAA). MTEC is currently recruiting a broad and diverse membership that includes representatives from large businesses, small businesses, "non-traditional" government contractors, academic research institutions and not-for-profit organizations. To be eligible, prototypes must fulfill a recognized research need/capability gap that will be described in the RPP and must be (at a minimum) Technology Readiness Level 4 (TRL 4). Proposals must have an overarching objective that demonstrates significant advancement in the readiness of the technology within a 12 month period of performance. Overall costs for an award may range from $150,000 - $300,000. Proposed efforts must be based on logical reasoning and sound scientific rationale. Please note that MTEC projects must eventually result in deliverables that transition medical solutions to industry. MTEC is excited to post this announcement for a Request for Project Proposals (RPP) for Prototype Acceleration Awards that will focus on advancing novel prototype technologies into the next major stage of development/milestone dependent upon their current maturity. Examples of the next major stage of development/milestone include, but are not limited to: late animal testing and regulatory filing, manufacturing, next clinical trial, regulatory approval, etc. The MTEC mission is to assist the U.S. Army Medical Research and Materiel Command (USAMRMC) by providing cutting-edge technologies and effective materiel life cycle management to transition medical solutions to industry that protect, treat, and optimize Warfighters' health and performance across the full spectrum of military operations. MTEC is a biomedical technology consortium collaborating with multiple government agencies under a 10-year renewable Other Transaction Agreement (OTA), Agreement No. W81XWH-15-9-0001, with the U.S. Army Medical Research Acquisition Activity (USAMRAA). MTEC is currently recruiting a broad and diverse membership that includes representatives from large businesses, small businesses, "non-traditional" government contractors, academic research institutions and not-for-profit organizations. To be eligible, prototypes must fulfill a recognized research need/capability gap that will be described in the RPP and must be (at a minimum) Technology Readiness Level 4 (TRL 4). Proposals must have an overarching objective that demonstrates significant advancement in the readiness of the technology within a 12 month period of performance. Overall costs for an award may range from $150,000 - $300,000. Proposed efforts must be based on logical reasoning and sound scientific rationale. Please note that MTEC projects must eventually result in deliverables that transition medical solutions to industry. The Prototype Acceleration Award mechanism is not intended to support basic research or research involving human subjects. Preliminary data is required. The technical focus areas for this Prototype Acceleration Award RPP are: Wound Care/Anti-infectives to include point of injury wound care • Novel platforms for the delivery of wound care anti-infectives, with a special emphasis on treatments that are integrated into dressings/bandages • Novel anti-infective therapies that have the ability to prevent the development of infections post-injury • Novel anti-infective therapies that reduce inflammation and pain sensation • Therapies to fight antimicrobial resistance • Novel treatments for skin/wound infection Regenerative Medicine • Biologic therapies for muscle regeneration with a special interest in the local delivery of therapeutics with biological activities (e.g., neuroprotective, neurotrophic) that promote muscle recovery post-trauma and slow muscle atrophy and degeneration. • Novel platforms for regenerative medicine applications to include: o bone regeneration o bone grafting o rebuilding tissues or skin after injury (e.g., autologous skin regeneration following burn injury) All Offerors responding to this prototype acceleration opportunity are required to be members of MTEC. To join MTEC, please visit http://mtec-sc.org/how-to-join/ For more information about the RPP, please visit the MTEC website, https://mtec-sc.org/active-solicitations/
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/USA/USAMRAA/DAMD17/MTEC-17-02/listing.html)
- Record
- SN04493558-W 20170504/170502235800-bad5d22c560f1aa064e56697261fa7ae (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |